Llowarch Poppy, Usselmann Laura, Ivanov Delyan, Holdgate Geoffrey A
High Throughput Screening, Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Alderley Park, United Kingdom.
Biophys Rev (Melville). 2023 May 16;4(2):021305. doi: 10.1063/5.0144141. eCollection 2023 Jun.
Thermal unfolding methods, applied in both isolated protein and cell-based settings, are increasingly used to identify and characterize hits during early drug discovery. Technical developments over recent years have facilitated their application in high-throughput approaches, and they now are used more frequently for primary screening. Widespread access to instrumentation and automation, the ability to miniaturize, as well as the capability and capacity to generate the appropriate scale and quality of protein and cell reagents have all played a part in these advances. As the nature of drug targets and approaches to their modulation have evolved, these methods have broadened our ability to provide useful chemical start points. Target proteins without catalytic function, or those that may be difficult to express and purify, are amenable to these methods. Here, we provide a review of the applications of thermal unfolding methods applied in hit finding during early drug discovery.
热变性方法,已应用于分离蛋白和基于细胞的环境中,在早期药物发现过程中越来越多地用于识别和表征活性化合物。近年来的技术发展推动了它们在高通量方法中的应用,现在它们更频繁地用于初筛。仪器设备和自动化的广泛普及、小型化的能力,以及生成适当规模和质量的蛋白质和细胞试剂的能力,都在这些进展中发挥了作用。随着药物靶点的性质及其调节方法的不断演变,这些方法拓宽了我们提供有用化学起始点的能力。没有催化功能的靶蛋白,或那些可能难以表达和纯化的蛋白,都适用于这些方法。在此,我们综述了热变性方法在早期药物发现过程中寻找活性化合物的应用。